AddLife, a Sweden-based company, which is primarily involved in the healthcare industry, agreed to acquire Vision Ophthalmology Group, a European distributor and manufacturer in ophthalmic surgery, eye surgery, for €165m. "We have been interested in the ophthalmology market for some time. The segment has all the critical characteristics to fit our business model, and it strengthens our position as an independent European niche player in Life Science. VOG has a strong management team that brings valuable experience in ophthalmology. This gives us a stable platform and good conditions to grow both organically and via acquisitions in an interesting area," Kristina Willgård, AddLife CEO.